Amy R. Dunn
Jackson Laboratory(US)Monash University(AU)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Neuroscience and Neuropharmacology Research, Adipose Tissue and Metabolism, Cellular transport and secretion, Parkinson's Disease Mechanisms and Treatments
Most-Cited Works
- → Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo(2014)238 cited
- → Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease(2017)153 cited
- → Gene-by-environment interactions in Alzheimer’s disease and Parkinson’s disease(2019)153 cited
- → The Synaptic Vesicle Glycoprotein 2: Structure, Function, and Disease Relevance(2019)110 cited
- → Increased Vesicular Monoamine Transporter 2 (VMAT2;Slc18a2) Protects against Methamphetamine Toxicity(2015)70 cited
- → Cognitive Reserve in Model Systems for Mechanistic Discovery: The Importance of Longitudinal Studies(2021)63 cited
- → Vesicular Monoamine Transporter 2 (VMAT2) Level Regulates MPTP Vulnerability and Clearance of Excess Dopamine in Mouse Striatal Terminals(2016)52 cited
- → Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo(2021)49 cited
- → Regulation of intrinsic excitability: Roles for learning and memory, aging and Alzheimer’s disease, and genetic diversity(2019)47 cited
- Relation Between Obesity and Blunted Striatal Response to Food Is Moderated by TaqIA A1 Allele(2008)